MTOR and neoplasm: Higher Neo-fs index was associated with International Society of Urological Pathology (ISUP) grade 1–2 (p < 0.001), pN0/pNx (p < 0.001), clear resection margin (p = 0.033), no AAA treatment (p = 0.009), and no mTOR inhibitor treatment (p = 0.016), although there was no difference with respect to sex, age, procedure, tumor size, pT stage, lymphovascular invasion, necrosis, or sarcomatoid change based on the Neo-fs index (Table S3).